STOCK TITAN

Avalo Therapeutics, Inc. (AVTX) Revenue by Year

AVTX

Avalo Therapeutics, Inc. generated $59K in revenue in fiscal year 2025. This represents a decrease of 86.6% from the prior fiscal year. The table below carries 13 fiscal years, from 2013 to 2025, and the quarters Avalo Therapeutics, Inc. has filed alongside them.

FY2025 annual
Revenue $59K
YoY -86.6%
5Y CAGR -61.2%
Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

AVTX Revenue by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY2510-KFY2410-KFY2310-KFY2210-KFY2110-KFY2010-KFY1910-KFY1810-KFY1710-KFY1610-KFY1510-KFY1410-KFY1310-K
Revenue$59K-86.6%$441K-77.1%$1.9M-89.3%$18.1M+234.4%$5.4M-19.4%$6.7M-0.8%$6.8M-4.0%$7.0M-74.7%$27.8M+2312.3%$1.2M$0N/AN/A

AVTX Revenue by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-KQ3'2310-Q
RevenueN/AN/AN/A$0-100.0%N/AN/AN/A$249K+5.5%$0-100.0%$0-100.0%$570K-36.4%$236K-98.4%

What revenue means

Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it.

More Avalo Therapeutics, Inc. financials

Frequently Asked Questions

What was Avalo Therapeutics, Inc.'s revenue in fiscal year 2025?

Avalo Therapeutics, Inc. generated $59K in revenue in fiscal year 2025.

How fast is Avalo Therapeutics, Inc.'s revenue growing?

Avalo Therapeutics, Inc. (AVTX) revenue fell by 86.6% year over year, from $441K to $59K in fiscal year 2025.

What does revenue mean on a financial statement?

Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it. This page lists what Avalo Therapeutics, Inc. (AVTX) reported on that line in every period on record.